Dipivefrin hydrochloride
CAS: 64019-93-8
Ref. 3D-FD152268
| 1g | Descontinuado | ||
| 5g | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
- 4-[1-Hydroxy-2-(Methylamino)Ethyl]Benzene-1,2-Diyl Bis(2,2-Dimethylpropanoate) Hydrochloride (1:1)
- D Epifrin
- Diopine
- Diphemin
- Dipivefrine HCL
- Dipivefrine hydrochloride
- Pivalephrine
- Propanoic acid, 2,2-dimethyl-, 1,1′-[4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene] ester, hydrochloride (1:1)
- Propanoic acid, 2,2-dimethyl-, 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester, hydrochloride
- Propine
- Ver mais sinónimos
Dipivefrin hydrochloride is a drug that belongs to the class of prostaglandin analogues. It is used as a topical ophthalmic solution for the treatment of glaucoma and other intraocular disorders. Dipivefrin hydrochloride is not active against microbial infection or choroidal neovascularization, but has been shown to be effective in the pharmacological treatment of metabolic disorders. This drug interacts with the prostaglandin receptors in the eye, which can lead to increased production of cyclic GMP (cGMP), a second messenger that causes relaxation of smooth muscles in blood vessels and leads to decreased intraocular pressure. Dipivefrin hydrochloride also has antimicrobial properties due to its ability to inhibit bacterial growth through binding with microbial cell membranes, thereby inhibiting protein synthesis.
